DayTwo, the food as medicine company that uses gut microbiome profiling to deliver precision nutrition, is the sole winner of the Roche Diabetes Care Innovation Contest.
“DayTwo is proud to be recognized by Roche and MATTER as the winner of the Roche Diabetes Care Innovation Contest. DayTwo looks forward to collaborating with Roche to leverage DayTwo’s microbiome platform and food as medicine solution with Roche’s Diabetes Care Ecosystem” said Lihi Segal, CEO and Co-Founder, DayTwo.
“We see a mountain-sized opportunity ahead of us — but thanks to the accelerator program our perspective has been sharpened and exciting opportunities are becoming visible right below the surface.” said Aaron Del Duca, Vice President of Microbiome Platform at DayTwo. “When we think of combining Roche’s strengths with our own knowledge base, we see a tremendous opportunity.”
Marco De Polo, head of strategic insights and open innovation at Roche shared, “At Roche we have discovered the unmet customer needs we want to target for value creation, and through this program, our goal has been to find the innovators out there who are expertly positioned to address those needs. DayTwo is one of those companies that is perfectly positioned to address unmet patient needs and solve multiple problems through a personalized nutrition solution.”
DayTwo’s medical nutrition therapy has been validated, in both clinical and employer-based settings, in lowering A1C and increasing Time In Glycemic Control, without the need to eliminate carbs or restrict calories. DayTwo’s diabetes clinical trial was conducted in partnership with Mayo Clinic and published in JAMA in 2019 and its recent prediabetes clinical trial was keynoted at the ADA’s 80th Scientific Sessions on June 14, 2020.
DayTwo’s contest team included Aaron Del Duca, Vice President of Microbiome Platform, Alan Spiro, M.D., EVP of Clinical Affairs, and John Desfosses, Director of Program Operations.
Thank you to the distinguished panel of judges:
● Jörg Hölzing – Global Head of Strategy & Customer Solutions, Roche
● Christophe Mauge – Global Head of R&D and Digital, Roche
● Lisa Huse – Regional Head of Marketing and Customer Experience, Roche Diabetes Care
● Stephen Ranjan – VP, Professional & Non-Insulin Therapy Franchise, Roche
● Steven Collens – CEO, MATTER Health